TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
VixiMed AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,084
|
1,869
|
2,377 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
225
|
-350
|
-15 |
EBITDA |
222
|
-338
|
0 |
Total assets |
1,219
|
1,085
|
1,561 |
Current assets |
1,219
|
1,045
|
1,549 |
Current liabilities |
410
|
435
|
600 |
Equity capital |
809
|
650
|
953 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
66.4%
|
59.9%
|
61.1% |
Turnover per employee |
2,084
|
1,869
|
2,377 |
Profit as a percentage of turnover |
10.8%
|
-18.7%
|
-0.6% |
Return on assets (ROA) |
18.5%
|
-32.3%
|
-1.0% |
Current ratio |
297.3%
|
240.2%
|
258.2% |
Return on equity (ROE) |
27.8%
|
-53.8%
|
-1.6% |
Change turnover |
215
|
-508
|
-317 |
Change turnover % |
12%
|
-21%
|
-12% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.